Literature DB >> 25005074

Experimental Autoimmune Encephalomyelitis in Mice.

Rachael L Terry1, Igal Ifergan, Stephen D Miller.   

Abstract

Experimental autoimmune encephalitis (EAE), the animal model of multiple sclerosis (MS), has provided significant insight into the mechanisms that initiate and drive autoimmunity. Several central nervous system proteins and peptides have been used to induce disease, in a number of different mouse strains, to model the diverse clinical presentations of MS. In this chapter, we detail the materials and methods used to induce active and adoptive EAE. We focus on disease induction in the SJL/J, C57BL/6, and BALB/c mouse strains, using peptides derived from proteolipid protein, myelin basic protein, and myelin oligodendrocyte glycoprotein. We also include a protocol for the isolation of leukocytes from the spinal cord and brain for flow cytometric analysis.

Entities:  

Mesh:

Year:  2016        PMID: 25005074      PMCID: PMC4402278          DOI: 10.1007/7651_2014_88

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  58 in total

1.  Differentiated Th1 autoreactive effector cells can induce experimental autoimmune encephalomyelitis in the absence of IL-12 and CD40/CD40L interactions.

Authors:  Itzhak Mendel; Ethan M Shevach
Journal:  J Neuroimmunol       Date:  2002-01       Impact factor: 3.478

2.  Identification of the encephalitogenic epitopes of CNS proteolipid protein in BALB/c mice.

Authors:  Jeri Anne Lyons; Michael J Ramsbottom; John L Trotter; Anne H Cross
Journal:  J Autoimmun       Date:  2002-12       Impact factor: 7.094

3.  Thiopalmitoylation of myelin proteolipid protein epitopes enhances immunogenicity and encephalitogenicity.

Authors:  J M Greer; B Denis; R A Sobel; E Trifilieff
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

4.  A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.

Authors:  L S Madsen; E C Andersson; L Jansson; M krogsgaard; C B Andersen; J Engberg; J L Strominger; A Svejgaard; J P Hjorth; R Holmdahl; K W Wucherpfennig; L Fugger
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

5.  Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains.

Authors:  I Tsunoda; L Q Kuang; D J Theil; R S Fujinami
Journal:  Brain Pathol       Date:  2000-07       Impact factor: 6.508

6.  A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction.

Authors:  D M Muller; M P Pender; J M Greer
Journal:  Acta Neuropathol       Date:  2000-08       Impact factor: 17.088

7.  De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.

Authors:  Stephen Mark Tompkins; Josette Padilla; Mauro C Dal Canto; Jenny P-Y Ting; Luc Van Kaer; Stephen D Miller
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

8.  Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system.

Authors:  Shin-Young Na; Yi Cao; Catherine Toben; Lars Nitschke; Christine Stadelmann; Ralf Gold; Anneliese Schimpl; Thomas Hünig
Journal:  Brain       Date:  2008-07-10       Impact factor: 13.501

9.  Constitutive expression of a costimulatory ligand on antigen-presenting cells in the nervous system drives demyelinating disease.

Authors:  Simone P Zehntner; Marcel Brisebois; Elise Tran; Trevor Owens; Sylvie Fournier
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

10.  Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

Authors:  Estelle Bettelli; Maria Pagany; Howard L Weiner; Christopher Linington; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  26 in total

1.  Involvement of interstitial cells of Cajal in bladder dysfunction in mice with experimental autoimmune encephalomyelitis.

Authors:  Zhibo Jin; Yinghui Ding; Rui Xue; Zhankui Jia; Zhenlin Huang; Yafei Ding; Chaohui Gu; Jinjian Yang
Journal:  Int Urol Nephrol       Date:  2017-04-19       Impact factor: 2.370

Review 2.  Wnt signaling in dendritic cells: its role in regulation of immunity and tolerance.

Authors:  Daniel Swafford; Santhakumar Manicassamy
Journal:  Discov Med       Date:  2015-04       Impact factor: 2.970

3.  Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.

Authors:  Su Ji Jeong; John G Cooper; Igal Ifergan; Tammy L McGuire; Dan Xu; Zoe Hunter; Sripadh Sharma; Derrick McCarthy; Stephen D Miller; John A Kessler
Journal:  Neurobiol Dis       Date:  2017-08-18       Impact factor: 5.996

Review 4.  Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis.

Authors:  Carol Chase Huizar; Itay Raphael; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2020-09-20       Impact factor: 4.868

5.  Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation.

Authors:  Amol Suryawanshi; Indumathi Manoharan; Yuan Hong; Daniel Swafford; Tanmay Majumdar; M Mark Taketo; Balaji Manicassamy; Pandelakis A Koni; Muthusamy Thangaraju; Zuoming Sun; Andrew L Mellor; David H Munn; Santhakumar Manicassamy
Journal:  J Immunol       Date:  2015-02-20       Impact factor: 5.422

6.  Targeting the GM-CSF receptor for the treatment of CNS autoimmunity.

Authors:  Igal Ifergan; Todd S Davidson; Hania Kebir; Dan Xu; Daphne Palacios-Macapagal; Jennifer Cann; Jane M Rodgers; Zoe N Hunter; Camille L Pittet; Sara Beddow; Clare A Jones; Alexandre Prat; Matthew A Sleeman; Stephen D Miller
Journal:  J Autoimmun       Date:  2017-06-20       Impact factor: 7.094

7.  Mouse Homologue of Human HLA-DO Does Not Preempt Autoimmunity but Controls Murine Gammaherpesvirus MHV68.

Authors:  Jean Lee; Emily Cullum; Kyle Stoltz; Niklas Bachmann; Zoe Strong; Danielle D Millick; Lisa K Denzin; Anthony Chang; Vera Tarakanova; Alexander V Chervonsky; Tatyana Golovkina
Journal:  J Immunol       Date:  2021-11-22       Impact factor: 5.426

8.  Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.

Authors:  Ryan C Winger; Christopher T Harp; Ming-Yi Chiang; David P Sullivan; Richard L Watson; Evan W Weber; Joseph R Podojil; Stephen D Miller; William A Muller
Journal:  J Immunol       Date:  2016-01-15       Impact factor: 5.422

9.  Meningeal B Cell Clusters Correlate with Submeningeal Pathology in a Natural Model of Multiple Sclerosis.

Authors:  Molly E Church; Guadalupe Ceja; Megan McGeehan; Miles C Miller; Priscilla Farias; Melissa D Sánchez; Gary P Swain; Charles-Antoine Assenmacher; Edward G Stopa; Charles H Vite; Amit Bar-Or; Jorge I Alvarez
Journal:  J Immunol       Date:  2021-06-23       Impact factor: 5.426

10.  Activation of Transcription Factor 4 in Dendritic Cells Controls Th1/Th17 Responses and Autoimmune Neuroinflammation.

Authors:  Indumathi Manoharan; Daniel Swafford; Arulkumaran Shanmugam; Nikhil Patel; Puttur D Prasad; Muthusamy Thangaraju; Santhakumar Manicassamy
Journal:  J Immunol       Date:  2021-08-04       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.